Graduate Program in Rehabilitation Sciences, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.
Graduate Program in Collective Health, Fiocruz, Belo Horizonte, MG, Brazil.
Braz J Phys Ther. 2021 Jul-Aug;25(4):444-449. doi: 10.1016/j.bjpt.2020.12.004. Epub 2020 Dec 16.
Previous validity studies of the Alberta Infant Motor Scale (AIMS), using raw scores and percentile curves for group comparisons, showed that infants in Brazil achieved gross motor milestones at later ages. Validity of the AIMS norms were later reassessed using a logistic regression model that placed the AIMS items on an age scale.
Our study examined the validity of the AIMS norms for Brazilian infants using the recommended method for calculating and comparing item locations.
Data from 732 Brazilian infants (2009-11), 3 days to 18 months old, were compared to the AIMS normative sample (n=2202). Logistic regression placed the AIMS items of both samples on age scales representing the age at which 50% of infants passed an item and compared the two datasets. Pearson correlation coefficient tested the association across samples.
47 of the 58 AIMS items met the criterion for stable regression to calculate item locations of the Brazilian dataset. Based on the age when 50% of the infants passed a criterion, most of the items from the Brazilian sample (n=28) differed by two weeks or less compared to the Canadian normative sample.
The sequence and age for the emergence of AIMS items were similar between the Brazilian and Canadian samples. Canadian norms are appropriate for clinical decisions and research with Brazilian infants.
先前使用原始分数和百分位曲线进行组间比较的艾伯塔婴儿运动量表(AIMS)有效性研究表明,巴西婴儿达到粗大运动里程碑的年龄较晚。后来,使用将 AIMS 项目置于年龄量表上的逻辑回归模型重新评估了 AIMS 标准的有效性。
我们的研究使用计算和比较项目位置的推荐方法来检验 AIMS 标准对巴西婴儿的有效性。
将 2009 年至 2011 年间 3 天至 18 个月大的 732 名巴西婴儿的数据与 AIMS 标准样本(n=2202)进行了比较。逻辑回归将两个样本的 AIMS 项目置于代表 50%婴儿通过项目的年龄尺度上,并比较了两个数据集。皮尔逊相关系数测试了两个样本之间的关联。
58 个 AIMS 项目中有 47 个符合稳定回归的标准,以计算巴西数据集的项目位置。基于 50%婴儿通过标准的年龄,巴西样本(n=28)中的大多数项目与加拿大标准样本相差两周或更短。
巴西和加拿大样本中 AIMS 项目的出现顺序和年龄相似。加拿大标准适用于巴西婴儿的临床决策和研究。